An association between clusterin over-expression and taxol-resistance in ovarian cancer.
Hassan
Mohamed Kamel
MK
Department of Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D045744:Cell Line, Tumor; D051152:Clusterin / Q000032:analysis*; D024921:Drug Resistance, Multiple, Viral / Q000502:physiology*; D005260:Female; D005434:Flow Cytometry; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D010051:Ovarian Neoplasms; D017239:Paclitaxel / Q000494:pharmacology*
D000972:Antineoplastic Agents, Phytogenic; D051152:Clusterin; D017239:Paclitaxel